Showing results (331-340 of 672) with videos related to
Sort By:
Pageof 68
Drugs|November 26, 2004
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitisFilip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.Healthcare (Basel, Switzerland)|January 10, 2026
From Hidden Insights to Better Understanding: Physicians' Perspectives on Caregivers' Tacit KnowledgeSylvia A Huisman, Kasper Kruithof, Maartje Hoogsteyns, et al.Royal Society Open Science|July 11, 2022
Northward range expansion of rooting ungulates decreases detritivore and predatory mite abundances in boreal forestsNadia I Maaroufi, Astrid R Taylor, Roswitha B Ehnes, et al.Journal of Genetic Counseling|July 9, 2020
Parental experiences of uncertainty following an abnormal fetal anomaly scan: Insights using Han's taxonomy of uncertaintyJennifer Hammond, Jasmijn E Klapwijk, Melissa Hill, et al.Scientific Reports|July 4, 2018
Hybrid rf SQUID qubit based on high kinetic inductanceJ T Peltonen, P C J J Coumou, Z H Peng, et al.Trials|July 3, 2024
A hybrid digital parenting programme to prevent abuse of adolescents in Tanzania: statistical analysis plan for a pragmatic cluster randomised controlled trialJonathan Klapwijk, G J Melendez-Torres, Abigail Ornellas, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 24, 2010
Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivoSuzanne M Bal, Annelieke C Kruithof, Raphaël Zwier, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1990
Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cellsJ F Cajot, J Bamat, G E Bergonzelli, et al.British Journal of Clinical Pharmacology|April 7, 2020
The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy male volunteersSebastiaan C Goulooze, Annelieke C Kruithof, Shanavas Alikunju, et al.Arthritis and Rheumatism|March 29, 2002
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathyFilip Van Den Bosch, Elli Kruithof, Dominique Baeten, et al.Pageof 68